Breast cancer is classified by stage, histology, and grade differentiation, and the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor‐2 (HER2/neu) determines the response of breast cancer cells to currently available chemotherapeutic drugs. Here, ERBB2 is linked to breast cancer.